Dyslipidemia management in patients with human immunodeficiency virus: A review

David M. Brett-Major*, Anuradha Ganesan

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


Both effective antiretroviral therapy and human immunodeficiency virus (HIV) infection have been associated with changes in serum lipids. Data on the relevance of this dyslipidemia on cardiovascular risk are growing. Although guidelines for managing dyslipidemia in HIV-infected patients are available, consideration of the changing literature is important to develop a stepwise approach for management. In this review, the 2003 guidelines of Infectious Diseases Society of America and HIV Medicine Association on dyslipidemia management of patients on antiretroviral therapy are merged with subsequent literature.

Original languageEnglish
Pages (from-to)7-16
Number of pages10
JournalInfectious Diseases in Clinical Practice
Issue number1
StatePublished - Jan 2007


Dive into the research topics of 'Dyslipidemia management in patients with human immunodeficiency virus: A review'. Together they form a unique fingerprint.

Cite this